Rafferty Asset Management, LLC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1389426
New York, NY
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,044,107
-$1,251,497 QoQ
Shares Held
181,676
-8.4% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. ACAD ranks #44 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,044,107 | 181,676 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,295,604 | 198,263 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,161,961 | 195,031 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,712,147 | 125,737 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,326,800 | 200,289 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,756,793 | 150,234 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,394,696 | 285,741 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,957,533 | 305,079 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,233,750 | 391,225 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,398,488 | 427,930 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,015,014 | 336,613 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,047,894 | 336,029 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $6,255,034 | 332,361 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,862,361 | 556,681 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,522,339 | 398,676 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,148,466 | 223,454 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,587,142 | 230,683 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,529,199 | 236,898 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,216,825 | 193,668 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,320,245 | 95,131 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,179,127 | 123,222 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $972,223 | 18,186 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,234,966 | 54,181 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,009,872 | 20,835 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $439,738 | 10,408 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||